title: UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly.
abstract: Testosterone and epitestosterone are endogenous steroids that differ in the configuration of the hydroxyl-bearing carbon at C-17. Testosterone is the predominant male sex hormone, whereas the role of epitestosterone is largely unclear. In humans, both androgens are excreted mainly as glucuronide conjugates and the urinary ratio of testosterone to epitestosterone (T/E), used to expose illicit testosterone abuse by male athletes, indicates the relative concentrations of the respective glucuronides. Some male athletes have T/E values greater than the accepted threshold value (4.0), even without testosterone abuse. We have analyzed athletes' urine samples and found that the main reason for such false-positive results in doping tests was a low epitestosterone glucuronide concentration not a high level of testosterone glucuronide. Sulfate conjugates of both testosterone and epitestosterone were also detected in the different urine samples. Glucuronidation assays with the 19 human UDP-glucuronosyltransferases (UGTs) of subfamilies UGT1A, UGT2A, and UGT2B revealed that UGT2B17 is the most active enzyme in testosterone glucuronidation. UGT2B17 does not glucuronidate epitestosterone, but inhibition studies revealed that it binds epitestosterone with affinity similar to that of testosterone. Epitestosterone glucuronidation is catalyzed mainly by UGT2B7, and the K(m) of this reaction is significantly lower than the K(m) of UGT2B17 for testosterone. Although UGT2B7 and UGT2B17 exhibited high, although converse, stereoselectivity in testosterone and epitestosterone glucuronidation, UGT2A1, an extrahepatic enzyme that is expressed mainly in the nasal epithelium, catalyzed the glucuronidation of both steroids at considerable rates and similar kinetics. The results shed new light on the substrate specificity and stereoselectivity of human UGTs.
authors.affiliation: Centre for Drug Research (CDR), Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5), FI-00014 University of Helsinki, Finland.
authors.forename: Taina
authors.initials: T
authors.lastname: Sten
authors.forename: Ingo
authors.initials: I
authors.lastname: Bichlmaier
authors.forename: Tiia
authors.initials: T
authors.lastname: Kuuranne
authors.forename: Antti
authors.initials: A
authors.lastname: Leinonen
authors.forename: Jari
authors.initials: J
authors.lastname: Yli-Kauhaluoma
authors.forename: Moshe
authors.initials: M
authors.lastname: Finel
mesh_terms: D000728:Androgens / Q000378:metabolism*; D004845:Epitestosterone / Q000378:metabolism*; D020719:Glucuronides; D014453:Glucuronosyltransferase / Q000378:metabolism*; D006801:Humans; D008297:Male; D055585:Physical Phenomena; D012680:Sensitivity and Specificity; D013379:Substrate Specificity; D013739:Testosterone / Q000031:analogs & derivatives* / Q000378:metabolism
chemical_list: D000728:Androgens; D020719:Glucuronides; C015529:testosterone glucuronate; D013739:Testosterone; D004845:Epitestosterone; C491474:UGT2B7 protein, human; D014453:Glucuronosyltransferase